Investors

EASTGATE BIOTECH ANNOUNCES THAT IT HAS RECEIVED A SUBSTANTIAL ORDER FOR GLUCORA, ITS NATURAL GLUCOSE MANAGEMENT PRODUCT

May 2, 2016 by admin

We are pleased that we have received our first material order for Glucora” says Anna Gluskin, EastGate Biotech’s CEO. “We believe that Glucora is a product with mass market appeal and will play a key role in the company’s diabetes franchise.

Read more

Eastgate Biotech CEO Anna Gluskin talks to ‘TheStockRadio.com’ about their products and delivery technology

February 8, 2016 by admin

We look forward to introducing the benefits of such delivery, that is now available through our nutraceutical products currently being sold on the market, to a larger audience” continues Gluskin.

Read more

EastGate Patent for Lorazopem

January 19, 2016 by admin

EASTGATE BIOTECH RECEIVES NOTICE OF PUBLICATION FROM THE US PATENT AND TRADEMARK OFFICE FOR TWO PATENTS FOR THE COMPANY’S PROPRIETARY INTRAORAL LORAZEPAM SPRAY

Read more

Do You Really Need An Antibiotic?

January 13, 2016 by admin

Shortly before I completed this column, I talked to a paraplegic patient who must use a catheter regularly to empty her bladder. This resulted in repeated infections in spite of five different antibiotics! She reported that use of UTI E-Drops resolved her dilemma.

Read more

uti-e-drops-order-2

January 6, 2016 by admin

Preferred Nutrition placed an order for E-drops which is the company’s natural and herbal alternative that assists to rid the body of UTI infections painlessly and effectively without side effects of synthetic drugs.

Read more

EASTGATE BIOTECH ANNOUNCES THE COMMENCEMENT OF SCALE-UP MANUFACTURING ACTIVITIES FOR ITS PROPRIETARY INTRAORAL INSULIN TABLET

September 29, 2015 by admin

To date, the company is successfully advancing in a formulation development of a 25 IU intraoral insulin tablet, designed to manage mealtime glucose levels.

Read more

EASTGATE BIOTECH CREATES AN ONLINE DIRECTORY AS A MARKETING TOOL FOR ITS NUTRACEUTICAL PRODUCT

September 24, 2015 by admin

EASTGATE BIOTECH CREATES AN ONLINE DIRECTORY AS A MARKETING TOOL FOR ITS NUTRACEUTICAL PRODUCT

Read more

UNIVERSITY OF GUELPH AND EASTGATE BIOTECH

July 7, 2015 by admin

Previously the company announced that its research collaboration with the University of Guelph involved measuring the antimicrobial activity of the company's natural antibacterial products, Cleanezze™ and Vclean™

Read more

EASTGATE BIOTECH ANNOUNCES THAT IMPEX HEALTHCARE WILL DISTRIBUTE ONE OF ITS PRODUCTS GLUCORA

June 16, 2015 by admin

EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company has announced that Impex Healthcare (www.ImpexHealthcare.com) will commence the distribution and marketing of one of the company’s natural products, Glucora, in Bangladesh along with future distribution of other glucose management products.

Read more

EASTGATE BIOTECH ANNOUNCES COLLABORATION WITH THE UNIVERSITY OF GUELPH, DEPARTMENT OF MOLECULAR AND CELLULAR BIOLOGY, FOR ITS NATURAL ANTIBACTERIAL PRODUCTS

May 28, 2015 by admin

EastGate Biotech Corp. (OTCBB: ETBI), has announced today its collaboration with the University of Guelph, Canada, Department of Molecular and Cellular Biology. The collaboration involves evaluation of the antimicrobial activity of the company’s natural antibacterial products, Cleanezze™ and VClean™.

Read more
RSS Icon